ConductScience.org, home

Paper34599863

Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.

Sun S and 7 others. Cancer Med, 2021. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy. Papers, record 34599863. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34599863

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.
PubMed
Journal
Cancer Med
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2024-08-17
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun SShengjie
2Du WWenjuan
3Sun QQiong
4Zhao XXiao
5Qin BBoyu
6Shi DDuozhihttps://orcid.org/0000-0002-3290-3461
7Wan CChong
8Wu ZZhiyong

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
GenomicsMajor topic
ImmunotherapyMajor topic
Lung NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Asian People
Cohort Studies
Female
Genetic Profile
Humans
Male
Middle Aged
Progression-Free Survival
Young Adult

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123988776EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.Eur Respir J2014https://conductscience.org/library/papers/23988776PubMed
225535693Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.J Thorac Oncol2015https://conductscience.org/library/papers/25535693PubMed
331297240Immune checkpoint inhibitor treatment in patients with oncogene- addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion.ESMO Open2019https://conductscience.org/library/papers/31297240PubMed
415647370Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15647370PubMed
530902917Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.Oncologist2019https://conductscience.org/library/papers/30902917PubMed
626051236Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.Lancet Oncol2015https://conductscience.org/library/papers/26051236PubMed
715696205KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.PLoS Med2005https://conductscience.org/library/papers/15696205PubMed
812032546p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.Nat Cell Biol2002https://conductscience.org/library/papers/12032546PubMed
915118125EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.Science2004https://conductscience.org/library/papers/15118125PubMed
1024346090
Large-scale screening and molecular characterization of EML4-ALK fusion variants in archival non-small-cell lung cancer tumor specimens using quantitative reverse transcription polymerase chain reaction assays.
J Thorac Oncol2014https://conductscience.org/library/papers/24346090PubMed
1123723294Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap).Ann Oncol2013https://conductscience.org/library/papers/23723294PubMed
1229989075GeneFuse: detection and visualization of target gene fusions from DNA sequencing data.Int J Biol Sci2018https://conductscience.org/library/papers/29989075PubMed
1322761469Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.Clin Cancer Res2012https://conductscience.org/library/papers/22761469PubMed
1422327623RET, ROS1 and ALK fusions in lung cancer.Nat Med2012https://conductscience.org/library/papers/22327623PubMed
1531611986Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer.Oncol Lett2019https://conductscience.org/library/papers/31611986PubMed
1631125062Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.Ann Oncol2019https://conductscience.org/library/papers/31125062PubMed
1723242438Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.J Thorac Oncol2013https://conductscience.org/library/papers/23242438PubMed
1821825258Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.J Clin Oncol2011https://conductscience.org/library/papers/21825258PubMed
1927151654
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
Oncologist2016https://conductscience.org/library/papers/27151654PubMed
2023630215Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.J Clin Oncol2013https://conductscience.org/library/papers/23630215PubMed

See all 54 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42453333Exploring the Impact of Multiple Gene Mutations on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Response in Asian Nonsmall Cell Lung Cancer Patients.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/42453333PubMed
39421181Prevalence and treatment of human epidermal growth factor receptor 2-altered non-small cell lung cancer: a retrospective analysis and systematic literature review.Ecancermedicalscience2024https://conductscience.org/library/papers/39421181PubMed
36256645Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer.PLoS One2022https://conductscience.org/library/papers/36256645PubMed
34599863Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.Cancer Med2021https://conductscience.org/library/papers/34599863PubMed

Download CSV of cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CCDC68030PubTator's text mininghttps://conductscience.org/library/genes/8030NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD74972PubTator's text mininghttps://conductscience.org/library/genes/972NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CLIP16249PubTator's text mininghttps://conductscience.org/library/genes/6249NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EML427436PubTator's text mininghttps://conductscience.org/library/genes/27436NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERC123085PubTator's text mininghttps://conductscience.org/library/genes/23085NCBI Gene
EZR7430PubTator's text mininghttps://conductscience.org/library/genes/7430NCBI Gene
FGFR12260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
HIP13092PubTator's text mininghttps://conductscience.org/library/genes/3092NCBI Gene
IGKV1-2728935PubTator's text mininghttps://conductscience.org/library/genes/28935NCBI Gene
KIF5B3799PubTator's text mininghttps://conductscience.org/library/genes/3799NCBI Gene
KIT3815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
LRIG3121227PubTator's text mininghttps://conductscience.org/library/genes/121227NCBI Gene

See all 31 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34599863

GET https://conductscience.org/api/papers/v1/34599863/references?page=2